XML 88 R49.htm IDEA: XBRL DOCUMENT v3.24.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2023
Disclosure of detailed information about financial instruments [abstract]  
Disclosure of financial assets and liabilities carrying values by category and fair values
Financial detail
The following tables provide the financial assets and liabilities carrying values by category and fair values as of December 31, 2023 and December 31, 2022:
As of 31/12/2022
Carrying valueFair value
As perAssets atAssets atAssets atDebt atLevel 1Level 2Level 3
statement offair valuefair valueamortizedamortized
financialthroughthrough OCIcostcost
(in € thousands)positionprofit & loss
Assets
Equity investments3,133 3,133 3,133 
Other investments483 483 483 
Financial investments4,550 4,550 4,550 
Loans428 428 428 
Deposits and guarantees335 335 335 
Liquidity contracts534 534 534 
Trade receivables3,188 3,188 3,188 
Cash and cash equivalents136,001 136,001 136,001 
TOTAL - Assets148,653 141,568 3,133 3,951  141,085 3,951 3,617 
Liabilities
Conditional advances3,229 3,229 3,229 
Convertible loans50,276 50,276 52,708 
Bank loans15,196 15,196 15,196 
Obligations under finance leases6,559 6,559 6,559 
Accrued interests14 14 14 
Trade payables8,613 8,613 8,613 
Other payables1,325 1,325 1,325 
TOTAL - Liabilities85,214    85,214  84,416 3,229 
As of 31/12/2023
Carrying valueFair value
As perAssets atAssets atAssets atDebt atLevel 1Level 2Level 3
statement offair valuefair valueamortizedamortized
financialthroughthrough OCIcostcost
(in € thousands)positionprofit & loss
Assets
Equity investments2,348 2,348 2,348 
Other investments471 471 471 
Loans472 472 472 
Deposits and guarantees303 303 303 
Liquidity contracts531 531 531 
Trade receivables18,526 18,526 18,526 
Cash and cash equivalents77,789 77,789 77,789 
TOTAL - Assets100,439 78,790 2,348 19,300  78,319 19,300 2,819 
Liabilities
Convertible loans52,622 52,622 51,939 
Bank loans11,578 11,578 11,578 
Obligations under finance leases5,884 5,884 5,884 
Accrued interests
Bank overdrafts89 89 89 
Trade payables10,448 10,448 10,448 
Other payables914 914 914 
TOTAL - Liabilities81,541    81,541  80,858  
It should be noted that the section above “Equity investments” concerns the nonconsolidated equity investments in Genoscience. The gross value of the asset is €3,133 and was partially impaired in 2023. See Note 18 - "Other financial assets".